Management of unusual histological types of breast cancer

Oncologist

Volumn 17, Issue 9, 2012, Pages 1135-1145

  Cadoo, Karen A ^a   McArdle, Orla ^a   O'Shea, Anne Marie ^a   Power, Colm P ^a   Hennessy, Bryan T ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Breast cancer; Histological types; Management

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; FLUOROURACIL; HERMES ANTIGEN; KI 67 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; MITOMYCIN C; PHOSPHATIDYLINOSITOL 3 KINASE; PREDNISONE; PROGESTERONE RECEPTOR; PROTEIN KINASE B; PROTEIN P53; TAMOXIFEN; TRANSCRIPTION FACTOR ETV6; VINDESINE;

ADENOID CYSTIC CARCINOMA; AGE; APOCRINE CARCINOMA; BREAST CANCER; CANCER GRADING; CANCER HORMONE THERAPY; CANCER PROGNOSIS; CELL PROLIFERATION; CLINICAL FEATURE; CRIBRIFORM CARCINOMA; DIFFERENTIAL DIAGNOSIS; DISTANT METASTASIS; GENDER; HISTOLOGY; HUMAN; IMAGING; INCIDENCE; LYMPH NODE; METAPLASTIC BREAST CANCER; PAPILLARY CARCINOMA; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SECRETORY BREAST CANCER; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

ADENOCARCINOMA; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, ADENOID CYSTIC; CARCINOMA, DUCTAL, BREAST; CARCINOMA, PAPILLARY; FEMALE; HUMANS; PROGNOSIS;

EID: 84866553736     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2012-0134     Document Type: Review

References (110)

1. Louwman MW, Vriezen M, van Beek MW et al. Uncommon breast tumors in perspective: Incidence, treatment and survival in the Netherlands. Int J Cancer 2007; 121:127-135.
2. Millar BA, Kerba M, Youngson B et al. The potential role of breast conservation surgery and adjuvant breast radiation for adenoid cystic carcinoma of the breast. Breast Cancer Res Treat 2004;87: 225-232.
3. Arpino G, Clark GM, Mohsin S et al.Adenoidcystic carcinoma of the breast: Molecular markers, treatment, and clinical outcome. Cancer 2002;94:2119-2127.
4. Matsuo K, Fukutomi T, Hasegawa T et al. Histological and immunohistochemical analysis of apocrine breast carcinoma. Breast Cancer 2002;9:43-49.
5. Mossler JA, Barton TK, Brinkhous AD et al. Apocrine differentiation in human mammary carcinoma. Cancer 1980;46:2463-2471.
6. Stutz JA, Evans AJ, Pinder S et al. The radiological appearances of invasive cribriform carcinoma of the breast. Nottingham Breast Team. Clin Radiol 1994;49: 693-695.
7. Page DL, Dixon JM, Anderson TJ et al. Invasive cribriform carcinoma of the breast. Histopathology 1983;7:525-536.
8. Pezzi CM, Patel-Parekh L, Cole K et al. Characteristics and treatment of metaplastic breast cancer: Analysis of 892 cases from the National Cancer Data Base. Ann Surg Oncol 2007;14:166-173.
9. Jung SY, Kim HY, Nam BH et al. Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer. Breast Cancer Res Treat 2010;120:627-637.
10. Al Sayed AD, El Weshi AN, Tulbah AM et al. Metaplastic carcinoma of the breast clinical presentation, treatment results and prognostic factors. Acta Oncol 2006;45:188-195.
11. Hennessy BT, Krishnamurthy S, Giordano S et al. Squamous cell carcinoma of the breast. J Clin Oncol 2005;23:7827-7835.
12. Yashar P, Sepahdari AR, Mahjoubi FD. Primary squamous cell carcinoma of the breast in an adult woman. Breast J 2006;12:571-572.
13. Toikkanen S. Primary squamous cell carcinoma of the breast. Cancer 1981;48:1629-1632.
14. Li CI, Moe RE, Daling JR. Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years. Arch Intern Med 2003;163:2149-2153.
15. Solorzano CC, Middleton LP, Hunt KK et al. Treatment and outcome of patients with intracystic papillary carcinoma of the breast. Am J Surg 2002;184:364-368.
16. Tixier H, Picard A, Guiu S et al. Longterm recurrence of secretory breast carcinoma with metastatic sentinellymphnodes. Arch Gynecol Obstet 2011;283(suppl 1):77-78.
17. Ghabach B, Anderson WF, Curtis RE et al. Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): A population-based cohort study. Breast Cancer Res 2010;12:R54.
18. Kleer CG, Oberman HA. Adenoid cystic carcinoma of the breast: Value of histologic grading and proliferative activity. Am J Surg Pathol 1998;22:569-575.
19. Verani RR, Van der Bel-Kahn J. Mammary adenoid cystic carcinoma with unusual features. Am J Clin Pathol 1973;59:653-658.
20. Nishimura R, Ohsumi S, Teramoto N et al. Invasive cribriform carcinoma with extensive microcalcifications in the male breast. Breast Cancer 2005;12:145-148.
21. Behranwala KA, Nasiri N, Abdullah N et al. Squamous cell carcinoma of the breast: Clinicopathologic implications and outcome. Eur J Surg Oncol 2003;29: 386-389.
22. Grabowski J, Salzstein SL, Sadler GR et al. Intracystic papillary carcinoma: A review of 917 cases. Cancer 2008;113:916-920.
23. de Bree E, Askoxylakis J, Giannikaki E et al. Secretory carcinoma of the male breast. Ann Surg Oncol 2002;9:663-667.
24. Szántó J, András C, Tsakiris J et al. Secretory breastcancerina7.5-yearoldboy.Breast 2004;13:439-442.
25. Longo OA, Mosto A, Moran JC et al. Breast carcinoma in childhood and adolescence: Case report and review of the literature. Breast J 1999;5:65-69.
26. Coates JM, Martinez SR, Bold RJ et al. Adjuvant radiation therapy is associated with improved survival for adenoid cystic carcinoma of the breast. J Surg Oncol 2010;102:342-347.
27. Hodgson NC, Lytwyn A, Bacopulos S et al. Adenoid cystic breast carcinoma: High rates of margin positivity after breast conserving surgery. Am J Clin Oncol 2010;33:28-31.
28. Japaze H, Emina J, Diaz C et al. 'Pure' invasive apocrine carcinoma of the breast: A new clinicopathological entity? Breast 2005;14:3-10.
29. Tanaka K, Imoto S, Wada N et al. Invasive apocrine carcinomaof the breast:Clinicopathologic features of 57 patients. Breast J 2008;14:164-168.
30. Luini A, Aguilar M, Gatti G et al. Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: The experience of the European Institute of Oncology and review of the literature. Breast Cancer Res Treat 2007;101:349-353.
31. Okada N, Hasebe T, Iwasaki M et al. Metaplastic carcinoma of the breast. Hum Pathol 2010;41:960-970.
32. Gn̈han-Bilgen I, Memis A, Ustun EE et al. Metaplastic carcinoma of the breast: Clinical, mammographic, and sonographic findings with histopathologic correlation. AJR Am J Roentgenol 2002;178:1421-1425.
33. Aparicio I, Martinez A, Hernández G et al. Squamous cell carcinoma of the breast. Eur J Obstet Gynecol Reprod Biol 2008;137:222-226.
34. Grabowski J, Saltzstein SL, Sadler G et al. Squamous cell carcinoma of the breast: A review of 177 cases. Am Surg 2009;75:914-917.
35. Li CI, Uribe DJ, Daling JR. Clinical characteristics of different histologic types of breast cancer. Br J Cancer 2005;93:1046-1052.
36. Fayanju OM, Ritter J, Gillanders WE et al. Therapeutic management of intracystic papillary carcinoma of the breast: The roles of radiation and endocrine therapy. Am J Surg 2007;194:497-500.
37. Ozguroglu M, Tascilar K, Ilvan S et al. Secretory carcinoma of the breast. Case report and review of the literature. Oncology 2005;68:263-268.
38. Vieni S, Cabibi D, Cipolla C et al. Secretory breast carcinoma with metastatic sentinel lymph node. World J Surg Oncol 2006;4:88.
39. Mun SH, Ko EY, Han BK et al. Secretory carcinoma of the breast: Sonographic features. J Ultrasound Med 2008;27:947-954.
40. Sarnaik AA, Meade T, King J et al. Adenoid cystic carcinoma of the breast: A review of a single institution's experience. Breast J 2010;16:208-210.
41. Abati AD, Kimmel M, Rosen PP. Apocrine mammary carcinoma. A clinicopathologic study of 72 cases. Am J Clin Pathol 1990;94:371-377.
42. Park JM, Han BK, Moon WK et al. Metaplasticcarcinoma of the breast: Mammographic and sonographic findings. J Clin Ultrasound 2000;28:179-186.
43. Comellas N, Marin Gutzke M. Primary pure squamous cell carcinoma of the breast presenting as a breast abscess. J Plast Reconstruct Aesthet Surg 2009;62: e178-e179.
44. Iglesias B, Monteagudo B, Rouco JS et al Secretory breast carcinoma in a 63-year-old man. J Cutan Pathol 2009;36(suppl 1):86-88.
45. Herz H, Cooke B, Goldstein D. Metastatic secretory breast cancer. Non-responsiveness to chemotherapy: Case report and review of the literature. Ann Oncol 2000;11:1343-1347.
46. Beatty SM, Orel SG, Kim P et al. Multicentric secretory carcinoma of the breast in a 35-year-old woman: Mammographic appearance and the use of core biopsy in preoperative management. Breast J 1998;4:200-203.
47. Ro JY, Silva EG, Gallager HS. Adenoid cystic carcinoma of the breast. Hum Pathol 1987;18:1276-1281.
48. Mastropasqua MG, Maiorano E, Pruneri G et al. Immunoreactivity for c-Kit and p63 as an adjunct in the diagnosis of adenoidcystic carcinoma of the breast. Mod Pathol 2005;18:1277-1282.
49. Azoulay S, Laé M, Fréneaux P et al. Kit is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome. Mod Pathol 2005;18:1623-1631.
50. Masood S, Rosa M. The challenge of apocrine proliferations of the breast: A morphologic approach. Pathol Res Pract 2009;205:155-164.
51. Venable JG, Schwartz AM, Silverberg SG. Infiltrating cribriform carcinoma of the breast: A distinctive clinicopathologic entity. Hum Pathol 1990;21:333-338.
52. Shousha S, Schoenfeld A, Moss J et al. Light and electron microscopic study of an invasive cribriform carcinoma with extensive microcalcification developing in a breast with silicone augmentation. Ultrastruct Pathol 1994;18:519-523.
53. Tavassoli FA, Devilee P, eds. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Breast and Female Genital Organs. Lyon, France: IARC Press, 2003:1-433.
54. Macia M, Ces JA, Becerra E et al. Pure squamous carcinoma of the breast. Report of a case diagnosed by aspiration cytology. Acta Cytol 1989;33:201-204.
55. Glazebrook KN, Reynolds C, Smith RL et al. Adenoid cystic carcinoma of the breast. AJR Am J Roentgenol 2010;194:1391-1396.
56. Gatti G, Pruneri G, Gilardi D et al. Reportonacase of pure cribriform carcinoma of the breast with internal mammary node metastasis: Description of the case and review of the literature. Tumori 2006;92:241-243.
57. Tashjian J, Kuni CC, Bohn LE. Primary squamous cell carcinoma of the breast: Mammographic findings. Can Assoc Radiol J 1989;40:228-229.
58. Murialdo R, Boy D, Musizzano Y et al. Squamous cell carcinoma of the breast: Acasereport. Cases J 2009; 2:7336.
59. Muttarak M, Lerttumnongtum P, Chaiwun B et al. Spectrum of papillary lesions of the breast: Clinical, imaging, and pathologic correlation. AJR Am J Roentgenol 2008;191:700-707.
60. Wagner AE, Middleton LP, Whitman GJ. Intracystic papillary carcinoma of the breast with invasion. AJR Am J Roentgenol 2004;183:1516.
61. Pal SK, Lau SK, Kruper L et al. Papillary carcinoma of the breast: An overview. Breast Cancer Res Treat 2010;122:637-645.
62. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with longterm follow-up. Histopathology 1991;19:403-410.
63. Rakha EA, Gandhi N, Climent F et al. Encapsulated papillary carcinoma of the breast: An invasive tumor with excellent prognosis. Am J Surg Pathol 2011; 35:1093-1103.
64. Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 2009;69:4116-4124.
65. Tse GM, Tan PH, Putti TC et al. Metaplastic carcinoma of the breast: A clinico pathological review. J Clin Pathol 2006;59:1079-1083.
66. Reis-Filho JS, Milanezi F, Steele D et al. Metaplastic breast carcinomas are basal-like tumours. Histopa-thology 2006;49:10-21.
67. Grenier J, Soria JC, Mathieu MC et al. Differential immuno histochemical and biological profile of squamous cell carcinoma of the breast. Anticancer Res 2007; 27:547-555.
68. Diallo R, Tognon C, Knezevich SR et al. Secretory carcinoma of the breast: A genetically defined carcinoma entity. Verh Dtsch Ges Pathol 2003;87:193-203.
69. Vranic S, Gatalica Z, Deng H et al.ER-α36, anovel isoform of ER-α66,iscommonlyover-expressedinapo-crine and adenoid cystic carcinomas of the breast. J Clin Pathol 2011;64:54-57.
70. Vranic S, Tawfik O, Palazzo J et al. EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast. Mod Pathol 2010;23:644-653.
71. Wynveen CA, Nehhozina T, Akram M et al. Intracystic papillary carcinoma of the breast: An in situ or invasive tumor? Results of immuno histochemical analysis and clinical follow-up. Am J Surg Pathol 2011;35:1-14.
72. Lim KH, Oh DY, Chie EK et al. Metaplastic breast carcinoma: Clinicopathologic features and prognostic value of triple negativity. Japan J Clin Oncol 2010;40: 112-118.
73. Baehner FL, Watson D, Ballard JT et al. Gene expression by standardized quantitative RT-PCR in the special histologic subtypes of estrogen receptor positive invasive breast cancer. Breast Cancer Res Treat 2007; 106:183.
74. Page DL. Adenoid cystic carcinoma of breast, a special histopathologic type with excellent prognosis. Breast Cancer Res Treat 2005;93:189-190.
75. Richard G, Hawk JC 3rd, Baker AS Jr et al. Multicentric adult secretory breast carcinoma: DNA flow cytometric findings, prognostic features, and review of the world literature. J Surg Oncol 1990;44:238-244.
76. Weigelt B, Horlings HM, Kreike B et al. Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol 2008; 216:141-150.
77. Berg JW, Hutter RV. Breast cancer. Cancer 1995; 75(1 suppl):257-269.
78. Costa NM, Rodrigues H, Pereira H et al. Secretory breast carcinomacase report and review of the medical literature. Breast 2004;13:353-355.
79. O'Malley FP, Bane A. An update on apocrine lesions of the breast. Histopathology 2008;52:3-10.
80. d'Amore ES, Terrier-Lacombe MJ, Travagli JP et al. Invasive apocrine carcinoma of the breast: A long term follow-up study of 34 cases. Breast Cancer Res Treat 1988;12:37-44.
81. Sapp M, Malik A, Hanna W. Hormone receptor profile of apocrine lesions of the breast. Breast J 2003; 9:335-336.
82. Gatalica Z. Immunohistochemical analysis of apocrine breast lesions. Consistent overexpression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ. Pathol Res Pract 1997;193:753-758.
83. Farmer P, Bonnefoi H, Becette V et al. Identification of molecular apocrine breast tumours by microarray analysis. Oncogene 2005;24:4660-4671.
84. Shi L, Dong B, Li Z et al. Expression of ER-α36, a novel variant of estrogen receptor?,and resistancetota-moxifen treatment in breast cancer. J Clin Oncol 2009; 27:3423-3429.
85. Marzullo F, Zito FA, Marzullo A et al. Infiltrating cribriform carcinoma of the breast. A clinico-pathologic and immunohistochemical study of 5 cases. Eur J Gynaecol Oncol 1996;17:228-231.
86. Ellis IO, Galea M, Broughton N et al. Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 1992;20:479-489.
87. Saleh F, Reno W. Invasive cribriform breast carcinomas in patients with grade 1 and stage IIA (T2N0M0) breast cancer strongly express the v3 and v6, but not the v4 isoforms of the metastatic marker CD44. Neoplasma 2008;55:246-255.
88. Bassarova AV, Torlakovic E, Sedloev T et al. Simultaneous bilateral breast carcinoma: Histopathological characteristics and CD44/catenincadherin profile. Histol Histopathol 2005;20:791-799.
89. Rayson D, Adjei AA, Suman VJ et al. Metaplastic breast cancer: Prognosis and response to systemic therapy. Ann Oncol 1999;10:413-419.
90. Chao TC, Wang CS, Chen SC et al. Metaplastic carcinomas of the breast. J Surg Oncol 1999;71:220-225.
91. Reis-Filho JS, Pinheiro C, Lambros MB et al. EGFR amplification and lack of activating mutations in metaplastic breast carcinomas. J Pathol 2006;209:445-453.
92. Brown-Glaberman U, Graham A, Stopeck A. A case of metaplastic carcinoma of the breast responsiveto chemotherapy with ifosfamide and etoposide: Improved antitumor response by targeting sarcomatous features. Breast J 2010;16:663-665.
93. Hennessy BT, Giordano S, Broglio K et al. Biphasic metaplastic sarcomatoid carcinoma of the breast. Ann Oncol 2006;17:605-613.
94. Winchester DJ, Winchester DP, Hudis CA, Norton L. Breast Cancer, Second Edition. Hamilton, Ontario, Canada: BC Decker, 2006:1-607.
95. Hiramatsu K, Kato K, Hirata A et al. [A resected case of squamous cell carcinoma of the breast successfully treated by FU plus cisplatin (CDDP) adjuvant therapy against recurrent metastases]. Gan To Kagaku Ryoho 2007;34:443-446.
96. Dejager D, Redlich PN, Dayer AM et al. Primary squamous cell carcinoma of the breast: Sensitivitytocis-platinum-based chemotherapy. J Surg Oncol 1995;59: 199-203.
97. Bhatt L, Fernando I. Primary squamous cell carcinoma of the breast: Achieving long-term control with cisplatin-basedchemo therapy. Clin Breast Cancer 2009; 9:187-188.
98. Kimura F, Iwaya K, Kawaguchi T et al. Epidermal growth factor-dependent enhancement of invasiveness of squamous cell carcinoma of the breast. Cancer Sci 2010;101:1133-1140.
99. Ueng SH, Mezzetti T, Tavassoli FA. Papillaryneoplasms of the breast: A review. Arch Pathol Lab Med 2009;133:893-907.
100. Collins LC, Schnitt SJ. Papillary lesions of the breast: Selected diagnostic and management issues. Histopathology 2008;52:20-29.
101. Collins LC, Carlo VP, Hwang H et al. Intracystic papillary carcinomas of the breast: A reevaluation using a panel of myoepithelial cell markers. Am J Surg Pathol 2006;30:1002-1007.
102. Mulligan AM, O'Malley FP. Metastatic potential of encapsulated (intracystic) papillary carcinoma of the breast: A report of 2 cases with axillary lymph node micrometastases. Int J Surg Pathol 2007;15:143-147.
103. Mulligan AM, O'Malley FP. Papillary lesions of the breast: A review. Adv Anat Pathol 2007;14:108-119.
104. Lambros MB, Tan DS, Jones RL et al. Genomic profile of a secretory breast cancer with an ETV6-NTRK3 duplication. J Clin Pathol 2009;62:604-612.
105. Hirokawa M, Sugihara K, Sai T et al. Secretory carcinoma of the breast: A tumour analogous to salivary gland acinic cell carcinoma? Histopathology 2002;40: 223-229.
106. Paeng MH, Choi HY, Sung SH et al. Secretory carcinomaofthebreast. J Clin Ultrasound 2003;31:425-429.
107. Laé M, Fréneaux P, Sastre-Garau X et al. Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum. Mod Pathol 2009;22:291-298.
108. Alenda C, Aranda FI, Segui FJ et al. Secretory carcinoma of the male breast: Correlation of aspiration cytology and pathology. Diagn Cytopathol 2005;32:47-50.
109. Amott DH, Masters R, Moore S. Secretory carcinoma of the breast. Breast J 2006;12:183.
110. Tognon C, Knezevich SR, Huntsman D et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2002;2:367-376.